<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364619">
  <stage>Registered</stage>
  <submitdate>18/07/2013</submitdate>
  <approvaldate>24/07/2013</approvaldate>
  <actrnumber>ACTRN12613000812796</actrnumber>
  <trial_identification>
    <studytitle>Outcomes 7 to 10 years following total hip replacement</studytitle>
    <scientifictitle>Dislocation, osteolysis, polyethylene wear, acetabular component migration and other complications 7 to 10 years following randomisation to either a large 36 mm or standard 28 mm diameter metal on highly cross-linked polyethylene articulation in total hip replacement </scientifictitle>
    <utrn>U1111-1145-7972</utrn>
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Dislocation of total hip replacement</healthcondition>
    <healthcondition>Periprosthetic osteolysis</healthcondition>
    <healthcondition>Polyethylene wear</healthcondition>
    <healthcondition>Acetabular component migration</healthcondition>
    <healthcondition>Revision or re-operation of total hip replacement</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The current study is a 7 to 10 year follow-up study of patients enrolled in the randomised controlled trial described in ACTRN12609000678291. Patients undergoing total hip replacement were randomised to receive either a large 36 mm articulation (intervention) or standard 28 mm articulation (control).</interventions>
    <comparator>Patients who, 7-10 years previously, underwent total hip replacement with a standard 28 mm articulation</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>% of patients with osteolytic lesions exceeding 1 cubic centimetre, as measured by CT </outcome>
      <timepoint>7-10 years following primary total hip replacement</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of dislocation. Dislocation is measured initially through responses to a Hip Instability Questionnaire and Hospital Visit Questionnaire. Dislocations must then be confirmed radiologically.</outcome>
      <timepoint>7 years following total hip replacement</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Polyethylene wear, measured using PolyWare, a computer program which measures wear using plain radiographs</outcome>
      <timepoint>7-10 years following total hip replacement</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Acetabular component migration, measured using EBRA (Ein Bild Roentgen Analyse), a computer program which measures migration using plain radiographs</outcome>
      <timepoint>7-10 years following total hip replacement</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>incidence of re-operation or revision of index total hip replacement</outcome>
      <timepoint>7 years following total hip replacement</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Other complications, such as infection, pain and loosening, as reported by patient</outcome>
      <timepoint>7 years following total hip replacement</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Only patients involved in the RCT, ACTRN12609000678291, will be eligible for this study</inclusivecriteria>
    <inclusiveminage>67</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Not previously enrolled in the RCT, ACTRN12609000678291</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods>The sample size is the number of patients still alive and able to undergo follow-up 7-10 years following enrollment in the randomised controlled trial.
Confidence intervals will reflect the available sample size of each analysis.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>24/03/2010</anticipatedstartdate>
    <actualstartdate>24/03/2010</actualstartdate>
    <anticipatedenddate>15/06/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>NSW,SA,VIC</recruitmentstate>
    <hospital>The Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>Royal North Shore Hospital - St Leonards</hospital>
    <hospital>St Vincent's Hospital (Melbourne) Ltd - Fitzroy</hospital>
    <hospital>St John of God Hospital, Ballarat - Ballarat</hospital>
    <hospital>Ballarat Health Services (Base Hospital) - Ballarat Central</hospital>
    <hospital>Maroondah Hospital - Ringwood East</hospital>
    <hospital>Barwon Health - Geelong Hospital campus - Geelong</hospital>
    <hospital>St Andrew's Hospital Inc - Adelaide</hospital>
    <hospital>Glenelg Community Hospital - Glenelg South</hospital>
    <hospital>Modbury Hospital - Modbury</hospital>
    <hospital>Whyalla Hospital - Whyalla</hospital>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>England</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Scotland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Prof Donald Howie</primarysponsorname>
    <primarysponsoraddress>Department of Orthopaedics and Trauma,
Level 4 Bice Building,
Royal Adelaide Hospital
North Tce
Adelaide SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health Medical Research Council (NHMRC)</fundingname>
      <fundingaddress>Level 1, 16 Marcus Clarke St Canberra ACT 2600</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Zimmer</fundingname>
      <fundingaddress>1800 W Center St Warsaw IN 46580</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Oksana Holubowycz</sponsorname>
      <sponsoraddress>Department of Orthopaedics and Trauma,
Level 4 Bice Building,
Royal Adelaide Hospital,
North Tce
Adelaide SA 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>At 7-10 years after total hip replacement, this study will determine the incidence of bone loss around a primary total hip prosthesis with a metal head and polyethylene liner, as determined by CT, as well as the wear of the polyethylene and the movement of the acetabular cup, as determined by plain radiographs. The study will also examine the incidence of dislocation and other symptoms of hip instability, as well as the reasons for revision or re-operation. In addition, the study will show if there are any differences in these outcomes between prostheses with standard 28 mm and large 36 mm femoral heads.</summary>
    <trialwebsite />
    <publication>Howie DW, Holubowycz OT, Middleton R, The Large Articulation Study Group. Large femoral heads decrease the incidence of dislocation after total hip arthroplasty. A randomized controlled trial. J Bone Joint Surg Am. 2012;94:1095-102.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Research Ethics Committee</ethicname>
      <ethicaddress>Royal Adelaide Hospital
North Tce 
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>13/10/2009</ethicapprovaldate>
      <hrec>RAH Protocol No. 090622</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Northern Sydney Central Coast Health (NSCCH) Human Research Ethics Committee</ethicname>
      <ethicaddress>Research Business Unit
Level 2, Building 51,
Royal North Shore Hospital
Pacific Hwy
St Leonards NSW 2065</ethicaddress>
      <ethicapprovaldate>13/12/2010</ethicapprovaldate>
      <hrec>1011-413M(QA)</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Ballarat Health Services &amp; St John of God Hospital HREC</ethicname>
      <ethicaddress>Ballarat Health Services
Drummond St N
Ballarat VIC 3350

</ethicaddress>
      <ethicapprovaldate>25/05/2011</ethicapprovaldate>
      <hrec>HREC/11/BHSSJOG/35</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>St Vincent's Hospital (Melbourne) Human Research Ethics Committee-D</ethicname>
      <ethicaddress>Research Governance Unit
St Vincent's Hospital Melbourne,
Level 5, Aikenhead Bldg,
41 Victoria Pde
Fitzroy VIC 3065</ethicaddress>
      <ethicapprovaldate>23/03/2012</ethicapprovaldate>
      <hrec>St Vincent's: HREC-A 001/12; SERP HREC: HREC/12/SVHM/22</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Eastern Health Research and Ethics Committee</ethicname>
      <ethicaddress>5 Arnold St
Box Hill VIC 3128</ethicaddress>
      <ethicapprovaldate>20/09/2012</ethicapprovaldate>
      <hrec>HREC/12/SVHM/22 &amp; Eastern Health Local Ref No: SERP25/1112</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Barwon Health</ethicname>
      <ethicaddress>Ryrie St
Geelong VIC 3220</ethicaddress>
      <ethicapprovaldate>3/05/2012</ethicapprovaldate>
      <hrec>HREC/12/SVHM/22; SSA Ref: SSA/12/VICBH/13; Barwon Health Ref: 12/30</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Donald Howie</name>
      <address>Department of Orthopaedics and Trauma, 
Level 4, Bice Building,
Royal Adelaide Hospital
North Tce 
Adelaide SA 5000</address>
      <phone>+61 8 8222 5563</phone>
      <fax />
      <email>donald.howie@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Oksana Holubowycz</name>
      <address>Department of Orthopaedics and Trauma, 
Level 4, Bice Building,
Royal Adelaide Hospital
North Tce 
Adelaide SA 5000</address>
      <phone>+61 8 8222 5760</phone>
      <fax />
      <email>oksana.holubowycz@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Oksana Holubowycz</name>
      <address>Department of Orthopaedics and Trauma, 
Level 4, Bice Building,
Royal Adelaide Hospital
North Tce 
Adelaide SA 5000</address>
      <phone>+61 8 8222 5760</phone>
      <fax />
      <email>oksana.holubowycz@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Oksana Holubowycz</name>
      <address>Department of Orthopaedics and Trauma, 
Level 4, Bice Building,
Royal Adelaide Hospital
North Tce 
Adelaide SA 5000</address>
      <phone>+61 8 8222 5760</phone>
      <fax />
      <email>oksana.holubowycz@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>